nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—Acitretin—psoriasis	0.0674	0.0992	CbGbCtD
Nortriptyline—CYP3A5—Beclomethasone—psoriasis	0.0638	0.0938	CbGbCtD
Nortriptyline—CYP1A2—Clobetasol propionate—psoriasis	0.0626	0.0921	CbGbCtD
Nortriptyline—CYP1A2—Methoxsalen—psoriasis	0.0329	0.0484	CbGbCtD
Nortriptyline—ALB—Mycophenolate mofetil—psoriasis	0.0316	0.0465	CbGbCtD
Nortriptyline—CYP2D6—Hydroxyurea—psoriasis	0.0296	0.0436	CbGbCtD
Nortriptyline—CYP3A5—Mycophenolate mofetil—psoriasis	0.0254	0.0373	CbGbCtD
Nortriptyline—ALB—Prednisone—psoriasis	0.0252	0.0371	CbGbCtD
Nortriptyline—CYP2C19—Cholecalciferol—psoriasis	0.0236	0.0347	CbGbCtD
Nortriptyline—CYP3A4—Calcitriol—psoriasis	0.0222	0.0326	CbGbCtD
Nortriptyline—CYP3A5—Hydrocortisone—psoriasis	0.0204	0.03	CbGbCtD
Nortriptyline—CYP2C9—Cholecalciferol—psoriasis	0.0196	0.0289	CbGbCtD
Nortriptyline—CYP3A5—Cyclosporine—psoriasis	0.0192	0.0283	CbGbCtD
Nortriptyline—CYP2D6—Cholecalciferol—psoriasis	0.018	0.0264	CbGbCtD
Nortriptyline—CYP3A4—Methoxsalen—psoriasis	0.0172	0.0253	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—psoriasis	0.0164	0.0241	CbGbCtD
Nortriptyline—CYP2E1—Dexamethasone—psoriasis	0.0163	0.024	CbGbCtD
Nortriptyline—CYP2C19—Cyclosporine—psoriasis	0.0155	0.0228	CbGbCtD
Nortriptyline—CYP2C9—Cyclosporine—psoriasis	0.0129	0.019	CbGbCtD
Nortriptyline—CYP3A5—Dexamethasone—psoriasis	0.0127	0.0186	CbGbCtD
Nortriptyline—ALB—Methotrexate—psoriasis	0.0127	0.0186	CbGbCtD
Nortriptyline—CYP2D6—Cyclosporine—psoriasis	0.0118	0.0174	CbGbCtD
Nortriptyline—CYP3A4—Cholecalciferol—psoriasis	0.0114	0.0168	CbGbCtD
Nortriptyline—CYP2C19—Dexamethasone—psoriasis	0.0102	0.015	CbGbCtD
Nortriptyline—CYP3A4—Triamcinolone—psoriasis	0.0099	0.0146	CbGbCtD
Nortriptyline—CYP3A4—Mycophenolate mofetil—psoriasis	0.0099	0.0146	CbGbCtD
Nortriptyline—CYP2C9—Dexamethasone—psoriasis	0.00849	0.0125	CbGbCtD
Nortriptyline—CYP3A4—Betamethasone—psoriasis	0.00849	0.0125	CbGbCtD
Nortriptyline—CYP3A4—Prednisolone—psoriasis	0.00838	0.0123	CbGbCtD
Nortriptyline—CYP3A4—Hydrocortisone—psoriasis	0.00794	0.0117	CbGbCtD
Nortriptyline—CYP3A4—Prednisone—psoriasis	0.00791	0.0116	CbGbCtD
Nortriptyline—CYP2D6—Dexamethasone—psoriasis	0.00777	0.0114	CbGbCtD
Nortriptyline—CYP3A4—Cyclosporine—psoriasis	0.0075	0.011	CbGbCtD
Nortriptyline—CYP3A4—Dexamethasone—psoriasis	0.00494	0.00727	CbGbCtD
Nortriptyline—Hypertension—Triamcinolone—psoriasis	0.000175	0.00067	CcSEcCtD
Nortriptyline—Insomnia—Mycophenolate mofetil—psoriasis	0.000174	0.000667	CcSEcCtD
Nortriptyline—Dyspepsia—Cyclosporine—psoriasis	0.000174	0.000666	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisolone—psoriasis	0.000174	0.000665	CcSEcCtD
Nortriptyline—Nausea—Hydroxyurea—psoriasis	0.000173	0.000663	CcSEcCtD
Nortriptyline—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000173	0.000662	CcSEcCtD
Nortriptyline—Pruritus—Mycophenolic acid—psoriasis	0.000173	0.000661	CcSEcCtD
Nortriptyline—Shock—Hydrocortisone—psoriasis	0.000173	0.000661	CcSEcCtD
Nortriptyline—Eye disorder—Prednisone—psoriasis	0.000172	0.000658	CcSEcCtD
Nortriptyline—Decreased appetite—Cyclosporine—psoriasis	0.000172	0.000657	CcSEcCtD
Nortriptyline—Tachycardia—Hydrocortisone—psoriasis	0.000171	0.000656	CcSEcCtD
Nortriptyline—Somnolence—Mycophenolate mofetil—psoriasis	0.000171	0.000656	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—psoriasis	0.000171	0.000655	CcSEcCtD
Nortriptyline—Flushing—Prednisone—psoriasis	0.000171	0.000653	CcSEcCtD
Nortriptyline—Ill-defined disorder—Betamethasone—psoriasis	0.00017	0.000653	CcSEcCtD
Nortriptyline—Ill-defined disorder—Dexamethasone—psoriasis	0.00017	0.000653	CcSEcCtD
Nortriptyline—Discomfort—Triamcinolone—psoriasis	0.00017	0.000652	CcSEcCtD
Nortriptyline—Fatigue—Cyclosporine—psoriasis	0.00017	0.000652	CcSEcCtD
Nortriptyline—Hyperhidrosis—Hydrocortisone—psoriasis	0.00017	0.00065	CcSEcCtD
Nortriptyline—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00017	0.000649	CcSEcCtD
Nortriptyline—Constipation—Cyclosporine—psoriasis	0.000169	0.000647	CcSEcCtD
Nortriptyline—Dry mouth—Triamcinolone—psoriasis	0.000169	0.000646	CcSEcCtD
Nortriptyline—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000167	0.000641	CcSEcCtD
Nortriptyline—Anorexia—Hydrocortisone—psoriasis	0.000167	0.000641	CcSEcCtD
Nortriptyline—Diarrhoea—Mycophenolic acid—psoriasis	0.000167	0.00064	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—psoriasis	0.000167	0.000639	CcSEcCtD
Nortriptyline—Malaise—Dexamethasone—psoriasis	0.000166	0.000635	CcSEcCtD
Nortriptyline—Malaise—Betamethasone—psoriasis	0.000166	0.000635	CcSEcCtD
Nortriptyline—Oedema—Triamcinolone—psoriasis	0.000165	0.000633	CcSEcCtD
Nortriptyline—Syncope—Betamethasone—psoriasis	0.000165	0.000631	CcSEcCtD
Nortriptyline—Syncope—Dexamethasone—psoriasis	0.000165	0.000631	CcSEcCtD
Nortriptyline—Constipation—Mycophenolate mofetil—psoriasis	0.000165	0.000631	CcSEcCtD
Nortriptyline—Arrhythmia—Prednisone—psoriasis	0.000164	0.000629	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—psoriasis	0.000164	0.000628	CcSEcCtD
Nortriptyline—Hypotension—Hydrocortisone—psoriasis	0.000164	0.000628	CcSEcCtD
Nortriptyline—Feeling abnormal—Cyclosporine—psoriasis	0.000163	0.000623	CcSEcCtD
Nortriptyline—Shock—Triamcinolone—psoriasis	0.000163	0.000623	CcSEcCtD
Nortriptyline—Insomnia—Prednisolone—psoriasis	0.000163	0.000622	CcSEcCtD
Nortriptyline—Alopecia—Prednisone—psoriasis	0.000162	0.000622	CcSEcCtD
Nortriptyline—Loss of consciousness—Dexamethasone—psoriasis	0.000161	0.000618	CcSEcCtD
Nortriptyline—Loss of consciousness—Betamethasone—psoriasis	0.000161	0.000618	CcSEcCtD
Nortriptyline—Dizziness—Mycophenolic acid—psoriasis	0.000161	0.000618	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisolone—psoriasis	0.000161	0.000618	CcSEcCtD
Nortriptyline—Tachycardia—Triamcinolone—psoriasis	0.000161	0.000618	CcSEcCtD
Nortriptyline—Hyperhidrosis—Triamcinolone—psoriasis	0.00016	0.000612	CcSEcCtD
Nortriptyline—Agranulocytosis—Methotrexate—psoriasis	0.00016	0.000612	CcSEcCtD
Nortriptyline—Convulsion—Betamethasone—psoriasis	0.000159	0.00061	CcSEcCtD
Nortriptyline—Convulsion—Dexamethasone—psoriasis	0.000159	0.00061	CcSEcCtD
Nortriptyline—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000159	0.000608	CcSEcCtD
Nortriptyline—Insomnia—Hydrocortisone—psoriasis	0.000159	0.000608	CcSEcCtD
Nortriptyline—Hypertension—Betamethasone—psoriasis	0.000159	0.000607	CcSEcCtD
Nortriptyline—Hypertension—Dexamethasone—psoriasis	0.000159	0.000607	CcSEcCtD
Nortriptyline—Paraesthesia—Hydrocortisone—psoriasis	0.000158	0.000604	CcSEcCtD
Nortriptyline—Urticaria—Cyclosporine—psoriasis	0.000157	0.000601	CcSEcCtD
Nortriptyline—Abdominal pain—Cyclosporine—psoriasis	0.000156	0.000598	CcSEcCtD
Nortriptyline—Body temperature increased—Cyclosporine—psoriasis	0.000156	0.000598	CcSEcCtD
Nortriptyline—Anxiety—Betamethasone—psoriasis	0.000156	0.000597	CcSEcCtD
Nortriptyline—Anxiety—Dexamethasone—psoriasis	0.000156	0.000597	CcSEcCtD
Nortriptyline—Vomiting—Mycophenolic acid—psoriasis	0.000155	0.000594	CcSEcCtD
Nortriptyline—Discomfort—Betamethasone—psoriasis	0.000155	0.000592	CcSEcCtD
Nortriptyline—Discomfort—Dexamethasone—psoriasis	0.000155	0.000592	CcSEcCtD
Nortriptyline—Dyspepsia—Hydrocortisone—psoriasis	0.000155	0.000592	CcSEcCtD
Nortriptyline—Rash—Mycophenolic acid—psoriasis	0.000154	0.000589	CcSEcCtD
Nortriptyline—Dermatitis—Mycophenolic acid—psoriasis	0.000154	0.000589	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—psoriasis	0.000154	0.000588	CcSEcCtD
Nortriptyline—Urticaria—Mycophenolate mofetil—psoriasis	0.000153	0.000586	CcSEcCtD
Nortriptyline—Headache—Mycophenolic acid—psoriasis	0.000153	0.000586	CcSEcCtD
Nortriptyline—Decreased appetite—Hydrocortisone—psoriasis	0.000153	0.000584	CcSEcCtD
Nortriptyline—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000152	0.000583	CcSEcCtD
Nortriptyline—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000152	0.000583	CcSEcCtD
Nortriptyline—Fatigue—Hydrocortisone—psoriasis	0.000151	0.000579	CcSEcCtD
Nortriptyline—Vision blurred—Prednisone—psoriasis	0.000151	0.000577	CcSEcCtD
Nortriptyline—Oedema—Betamethasone—psoriasis	0.00015	0.000574	CcSEcCtD
Nortriptyline—Oedema—Dexamethasone—psoriasis	0.00015	0.000574	CcSEcCtD
Nortriptyline—Insomnia—Triamcinolone—psoriasis	0.000149	0.000572	CcSEcCtD
Nortriptyline—Ill-defined disorder—Prednisone—psoriasis	0.000148	0.000569	CcSEcCtD
Nortriptyline—Paraesthesia—Triamcinolone—psoriasis	0.000148	0.000568	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisolone—psoriasis	0.000148	0.000567	CcSEcCtD
Nortriptyline—Shock—Dexamethasone—psoriasis	0.000148	0.000565	CcSEcCtD
Nortriptyline—Shock—Betamethasone—psoriasis	0.000148	0.000565	CcSEcCtD
Nortriptyline—Agitation—Prednisone—psoriasis	0.000147	0.000563	CcSEcCtD
Nortriptyline—Thrombocytopenia—Dexamethasone—psoriasis	0.000147	0.000562	CcSEcCtD
Nortriptyline—Thrombocytopenia—Betamethasone—psoriasis	0.000147	0.000562	CcSEcCtD
Nortriptyline—Tachycardia—Dexamethasone—psoriasis	0.000146	0.00056	CcSEcCtD
Nortriptyline—Tachycardia—Betamethasone—psoriasis	0.000146	0.00056	CcSEcCtD
Nortriptyline—Hypersensitivity—Cyclosporine—psoriasis	0.000146	0.000557	CcSEcCtD
Nortriptyline—Dyspepsia—Triamcinolone—psoriasis	0.000145	0.000557	CcSEcCtD
Nortriptyline—Nausea—Mycophenolic acid—psoriasis	0.000145	0.000555	CcSEcCtD
Nortriptyline—Hyperhidrosis—Dexamethasone—psoriasis	0.000145	0.000555	CcSEcCtD
Nortriptyline—Hyperhidrosis—Betamethasone—psoriasis	0.000145	0.000555	CcSEcCtD
Nortriptyline—Feeling abnormal—Hydrocortisone—psoriasis	0.000145	0.000554	CcSEcCtD
Nortriptyline—Malaise—Prednisone—psoriasis	0.000144	0.000553	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—psoriasis	0.000144	0.00055	CcSEcCtD
Nortriptyline—Syncope—Prednisone—psoriasis	0.000143	0.00055	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—psoriasis	0.000143	0.000548	CcSEcCtD
Nortriptyline—Anorexia—Dexamethasone—psoriasis	0.000143	0.000547	CcSEcCtD
Nortriptyline—Anorexia—Betamethasone—psoriasis	0.000143	0.000547	CcSEcCtD
Nortriptyline—Urticaria—Prednisolone—psoriasis	0.000143	0.000547	CcSEcCtD
Nortriptyline—Fatigue—Triamcinolone—psoriasis	0.000142	0.000546	CcSEcCtD
Nortriptyline—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000142	0.000544	CcSEcCtD
Nortriptyline—Asthenia—Cyclosporine—psoriasis	0.000142	0.000543	CcSEcCtD
Nortriptyline—Loss of consciousness—Prednisone—psoriasis	0.000141	0.000539	CcSEcCtD
Nortriptyline—Hypotension—Betamethasone—psoriasis	0.00014	0.000537	CcSEcCtD
Nortriptyline—Hypotension—Dexamethasone—psoriasis	0.00014	0.000537	CcSEcCtD
Nortriptyline—Pruritus—Cyclosporine—psoriasis	0.00014	0.000535	CcSEcCtD
Nortriptyline—Urticaria—Hydrocortisone—psoriasis	0.000139	0.000534	CcSEcCtD
Nortriptyline—Abdominal pain—Hydrocortisone—psoriasis	0.000139	0.000531	CcSEcCtD
Nortriptyline—Body temperature increased—Hydrocortisone—psoriasis	0.000139	0.000531	CcSEcCtD
Nortriptyline—Convulsion—Prednisone—psoriasis	0.000139	0.000531	CcSEcCtD
Nortriptyline—Asthenia—Mycophenolate mofetil—psoriasis	0.000138	0.000529	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—psoriasis	0.000138	0.000529	CcSEcCtD
Nortriptyline—Pruritus—Mycophenolate mofetil—psoriasis	0.000136	0.000522	CcSEcCtD
Nortriptyline—Feeling abnormal—Triamcinolone—psoriasis	0.000136	0.000522	CcSEcCtD
Nortriptyline—Anxiety—Prednisone—psoriasis	0.000136	0.00052	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—psoriasis	0.000136	0.00052	CcSEcCtD
Nortriptyline—Insomnia—Dexamethasone—psoriasis	0.000136	0.000519	CcSEcCtD
Nortriptyline—Insomnia—Betamethasone—psoriasis	0.000136	0.000519	CcSEcCtD
Nortriptyline—Diarrhoea—Cyclosporine—psoriasis	0.000135	0.000517	CcSEcCtD
Nortriptyline—Paraesthesia—Dexamethasone—psoriasis	0.000135	0.000516	CcSEcCtD
Nortriptyline—Paraesthesia—Betamethasone—psoriasis	0.000135	0.000516	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—psoriasis	0.000135	0.000515	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisolone—psoriasis	0.000132	0.000507	CcSEcCtD
Nortriptyline—Dyspepsia—Dexamethasone—psoriasis	0.000132	0.000505	CcSEcCtD
Nortriptyline—Dyspepsia—Betamethasone—psoriasis	0.000132	0.000505	CcSEcCtD
Nortriptyline—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000132	0.000505	CcSEcCtD
Nortriptyline—Urticaria—Triamcinolone—psoriasis	0.000131	0.000503	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—psoriasis	0.000131	0.000501	CcSEcCtD
Nortriptyline—Body temperature increased—Triamcinolone—psoriasis	0.000131	0.0005	CcSEcCtD
Nortriptyline—Dizziness—Cyclosporine—psoriasis	0.000131	0.0005	CcSEcCtD
Nortriptyline—Oedema—Prednisone—psoriasis	0.000131	0.0005	CcSEcCtD
Nortriptyline—Decreased appetite—Dexamethasone—psoriasis	0.00013	0.000499	CcSEcCtD
Nortriptyline—Decreased appetite—Betamethasone—psoriasis	0.00013	0.000499	CcSEcCtD
Nortriptyline—Hypersensitivity—Hydrocortisone—psoriasis	0.000129	0.000495	CcSEcCtD
Nortriptyline—Fatigue—Dexamethasone—psoriasis	0.000129	0.000495	CcSEcCtD
Nortriptyline—Fatigue—Betamethasone—psoriasis	0.000129	0.000495	CcSEcCtD
Nortriptyline—Shock—Prednisone—psoriasis	0.000128	0.000492	CcSEcCtD
Nortriptyline—Tachycardia—Prednisone—psoriasis	0.000127	0.000488	CcSEcCtD
Nortriptyline—Dizziness—Mycophenolate mofetil—psoriasis	0.000127	0.000488	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisone—psoriasis	0.000126	0.000483	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—psoriasis	0.000126	0.000483	CcSEcCtD
Nortriptyline—Asthenia—Hydrocortisone—psoriasis	0.000126	0.000482	CcSEcCtD
Nortriptyline—Vomiting—Cyclosporine—psoriasis	0.000126	0.000481	CcSEcCtD
Nortriptyline—Rash—Cyclosporine—psoriasis	0.000125	0.000477	CcSEcCtD
Nortriptyline—Anorexia—Prednisone—psoriasis	0.000124	0.000477	CcSEcCtD
Nortriptyline—Dermatitis—Cyclosporine—psoriasis	0.000124	0.000476	CcSEcCtD
Nortriptyline—Pruritus—Hydrocortisone—psoriasis	0.000124	0.000476	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—psoriasis	0.000124	0.000475	CcSEcCtD
Nortriptyline—Headache—Cyclosporine—psoriasis	0.000124	0.000474	CcSEcCtD
Nortriptyline—Feeling abnormal—Dexamethasone—psoriasis	0.000124	0.000473	CcSEcCtD
Nortriptyline—Feeling abnormal—Betamethasone—psoriasis	0.000124	0.000473	CcSEcCtD
Nortriptyline—Vomiting—Mycophenolate mofetil—psoriasis	0.000122	0.000469	CcSEcCtD
Nortriptyline—Hypersensitivity—Triamcinolone—psoriasis	0.000122	0.000466	CcSEcCtD
Nortriptyline—Rash—Mycophenolate mofetil—psoriasis	0.000121	0.000465	CcSEcCtD
Nortriptyline—Dermatitis—Mycophenolate mofetil—psoriasis	0.000121	0.000465	CcSEcCtD
Nortriptyline—Headache—Mycophenolate mofetil—psoriasis	0.000121	0.000462	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—psoriasis	0.000121	0.000462	CcSEcCtD
Nortriptyline—Diarrhoea—Hydrocortisone—psoriasis	0.00012	0.00046	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—psoriasis	0.00012	0.000458	CcSEcCtD
Nortriptyline—Urticaria—Betamethasone—psoriasis	0.000119	0.000456	CcSEcCtD
Nortriptyline—Urticaria—Dexamethasone—psoriasis	0.000119	0.000456	CcSEcCtD
Nortriptyline—Dizziness—Prednisolone—psoriasis	0.000119	0.000455	CcSEcCtD
Nortriptyline—Asthenia—Triamcinolone—psoriasis	0.000119	0.000454	CcSEcCtD
Nortriptyline—Body temperature increased—Betamethasone—psoriasis	0.000119	0.000454	CcSEcCtD
Nortriptyline—Body temperature increased—Dexamethasone—psoriasis	0.000119	0.000454	CcSEcCtD
Nortriptyline—Abdominal pain—Betamethasone—psoriasis	0.000119	0.000454	CcSEcCtD
Nortriptyline—Abdominal pain—Dexamethasone—psoriasis	0.000119	0.000454	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—psoriasis	0.000118	0.000452	CcSEcCtD
Nortriptyline—Nausea—Cyclosporine—psoriasis	0.000117	0.000449	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—psoriasis	0.000117	0.000449	CcSEcCtD
Nortriptyline—Pruritus—Triamcinolone—psoriasis	0.000117	0.000448	CcSEcCtD
Nortriptyline—Dizziness—Hydrocortisone—psoriasis	0.000116	0.000444	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—psoriasis	0.000116	0.000444	CcSEcCtD
Nortriptyline—Dyspepsia—Prednisone—psoriasis	0.000115	0.00044	CcSEcCtD
Nortriptyline—Nausea—Mycophenolate mofetil—psoriasis	0.000114	0.000438	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—psoriasis	0.000114	0.000435	CcSEcCtD
Nortriptyline—Rash—Prednisolone—psoriasis	0.000113	0.000434	CcSEcCtD
Nortriptyline—Dermatitis—Prednisolone—psoriasis	0.000113	0.000434	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—psoriasis	0.000113	0.000431	CcSEcCtD
Nortriptyline—Headache—Prednisolone—psoriasis	0.000113	0.000431	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—psoriasis	0.000112	0.000431	CcSEcCtD
Nortriptyline—Constipation—Prednisone—psoriasis	0.000112	0.000428	CcSEcCtD
Nortriptyline—Vomiting—Hydrocortisone—psoriasis	0.000112	0.000427	CcSEcCtD
Nortriptyline—Rash—Hydrocortisone—psoriasis	0.000111	0.000424	CcSEcCtD
Nortriptyline—Dermatitis—Hydrocortisone—psoriasis	0.000111	0.000423	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—psoriasis	0.00011	0.000421	CcSEcCtD
Nortriptyline—Headache—Hydrocortisone—psoriasis	0.00011	0.000421	CcSEcCtD
Nortriptyline—Dizziness—Triamcinolone—psoriasis	0.000109	0.000419	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—psoriasis	0.000108	0.000412	CcSEcCtD
Nortriptyline—Asthenia—Dexamethasone—psoriasis	0.000108	0.000412	CcSEcCtD
Nortriptyline—Asthenia—Betamethasone—psoriasis	0.000108	0.000412	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—psoriasis	0.000107	0.000409	CcSEcCtD
Nortriptyline—Nausea—Prednisolone—psoriasis	0.000107	0.000409	CcSEcCtD
Nortriptyline—Pruritus—Betamethasone—psoriasis	0.000106	0.000406	CcSEcCtD
Nortriptyline—Pruritus—Dexamethasone—psoriasis	0.000106	0.000406	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—psoriasis	0.000106	0.000404	CcSEcCtD
Nortriptyline—Vomiting—Triamcinolone—psoriasis	0.000105	0.000402	CcSEcCtD
Nortriptyline—Nausea—Hydrocortisone—psoriasis	0.000104	0.000399	CcSEcCtD
Nortriptyline—Rash—Triamcinolone—psoriasis	0.000104	0.000399	CcSEcCtD
Nortriptyline—Dermatitis—Triamcinolone—psoriasis	0.000104	0.000399	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—psoriasis	0.000104	0.000398	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—psoriasis	0.000104	0.000397	CcSEcCtD
Nortriptyline—Headache—Triamcinolone—psoriasis	0.000104	0.000396	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—psoriasis	0.000103	0.000395	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—psoriasis	0.000103	0.000395	CcSEcCtD
Nortriptyline—Diarrhoea—Dexamethasone—psoriasis	0.000103	0.000393	CcSEcCtD
Nortriptyline—Diarrhoea—Betamethasone—psoriasis	0.000103	0.000393	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—psoriasis	0.000102	0.000391	CcSEcCtD
Nortriptyline—Dizziness—Dexamethasone—psoriasis	9.92e-05	0.00038	CcSEcCtD
Nortriptyline—Dizziness—Betamethasone—psoriasis	9.92e-05	0.00038	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—psoriasis	9.87e-05	0.000378	CcSEcCtD
Nortriptyline—Nausea—Triamcinolone—psoriasis	9.82e-05	0.000376	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—psoriasis	9.8e-05	0.000375	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—psoriasis	9.7e-05	0.000372	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisone—psoriasis	9.62e-05	0.000368	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—psoriasis	9.61e-05	0.000368	CcSEcCtD
Nortriptyline—Vomiting—Betamethasone—psoriasis	9.53e-05	0.000365	CcSEcCtD
Nortriptyline—Vomiting—Dexamethasone—psoriasis	9.53e-05	0.000365	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—psoriasis	9.49e-05	0.000363	CcSEcCtD
Nortriptyline—Rash—Dexamethasone—psoriasis	9.46e-05	0.000362	CcSEcCtD
Nortriptyline—Rash—Betamethasone—psoriasis	9.46e-05	0.000362	CcSEcCtD
Nortriptyline—Dermatitis—Betamethasone—psoriasis	9.45e-05	0.000362	CcSEcCtD
Nortriptyline—Dermatitis—Dexamethasone—psoriasis	9.45e-05	0.000362	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—psoriasis	9.41e-05	0.00036	CcSEcCtD
Nortriptyline—Headache—Dexamethasone—psoriasis	9.39e-05	0.00036	CcSEcCtD
Nortriptyline—Headache—Betamethasone—psoriasis	9.39e-05	0.00036	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—psoriasis	9.37e-05	0.000359	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—psoriasis	9.24e-05	0.000354	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—psoriasis	8.99e-05	0.000344	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—psoriasis	8.94e-05	0.000342	CcSEcCtD
Nortriptyline—Nausea—Betamethasone—psoriasis	8.91e-05	0.000341	CcSEcCtD
Nortriptyline—Nausea—Dexamethasone—psoriasis	8.91e-05	0.000341	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—psoriasis	8.67e-05	0.000332	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—psoriasis	8.64e-05	0.000331	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—psoriasis	8.63e-05	0.00033	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—psoriasis	8.63e-05	0.00033	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—psoriasis	8.3e-05	0.000318	CcSEcCtD
Nortriptyline—Rash—Prednisone—psoriasis	8.23e-05	0.000315	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—psoriasis	8.23e-05	0.000315	CcSEcCtD
Nortriptyline—Headache—Prednisone—psoriasis	8.18e-05	0.000313	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—psoriasis	8.04e-05	0.000308	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—psoriasis	7.83e-05	0.0003	CcSEcCtD
Nortriptyline—Nausea—Prednisone—psoriasis	7.76e-05	0.000297	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—psoriasis	7.72e-05	0.000296	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—psoriasis	7.47e-05	0.000286	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—psoriasis	7.22e-05	0.000276	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—psoriasis	6.94e-05	0.000266	CcSEcCtD
Nortriptyline—Rash—Methotrexate—psoriasis	6.88e-05	0.000264	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—psoriasis	6.88e-05	0.000263	CcSEcCtD
Nortriptyline—Headache—Methotrexate—psoriasis	6.84e-05	0.000262	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—psoriasis	6.48e-05	0.000248	CcSEcCtD
Nortriptyline—CHRM5—Signaling by GPCR—CXCL8—psoriasis	1.34e-05	0.000228	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.33e-05	0.000226	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.33e-05	0.000225	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—LEP—psoriasis	1.32e-05	0.000224	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—APOE—psoriasis	1.32e-05	0.000224	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.32e-05	0.000223	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CAT—psoriasis	1.29e-05	0.000219	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.28e-05	0.000216	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000214	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	1.26e-05	0.000214	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000214	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000213	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CARM1—psoriasis	1.25e-05	0.000212	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—APOE—psoriasis	1.25e-05	0.000211	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—LEP—psoriasis	1.25e-05	0.000211	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CARM1—psoriasis	1.24e-05	0.000211	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000209	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000205	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000204	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000204	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—LEP—psoriasis	1.19e-05	0.000202	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—APOE—psoriasis	1.19e-05	0.000202	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SOCS1—psoriasis	1.16e-05	0.000197	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.16e-05	0.000197	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.000197	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.000196	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.15e-05	0.000194	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000194	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.14e-05	0.000193	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000193	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000192	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—APOE—psoriasis	1.13e-05	0.000191	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.13e-05	0.00019	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—LEP—psoriasis	1.12e-05	0.00019	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—APOE—psoriasis	1.12e-05	0.00019	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.00019	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NFKBIA—psoriasis	1.11e-05	0.000188	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—TYK2—psoriasis	1.11e-05	0.000188	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000186	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000185	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000185	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000185	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CAT—psoriasis	1.09e-05	0.000184	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000184	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CAT—psoriasis	1.09e-05	0.000184	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—TYK2—psoriasis	1.08e-05	0.000183	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000182	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000181	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.06e-05	0.00018	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CARM1—psoriasis	1.06e-05	0.00018	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000178	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.05e-05	0.000177	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.05e-05	0.000177	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.05e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000174	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000174	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TYK2—psoriasis	1.01e-05	0.000171	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—APOE—psoriasis	1e-05	0.00017	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.94e-06	0.000168	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PPARG—psoriasis	9.85e-06	0.000167	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APOE—psoriasis	9.79e-06	0.000166	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—LEP—psoriasis	9.79e-06	0.000166	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—LEP—psoriasis	9.74e-06	0.000165	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APOE—psoriasis	9.74e-06	0.000165	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—CXCL8—psoriasis	9.67e-06	0.000164	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—psoriasis	9.67e-06	0.000164	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TYK2—psoriasis	9.52e-06	0.000161	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—CXCL8—psoriasis	9.51e-06	0.000161	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—CXCL8—psoriasis	9.49e-06	0.000161	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—CXCL8—psoriasis	9.46e-06	0.00016	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—CXCL8—psoriasis	9.43e-06	0.00016	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CAT—psoriasis	9.35e-06	0.000158	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—CXCL8—psoriasis	9.34e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—LEP—psoriasis	9.32e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APOE—psoriasis	9.32e-06	0.000158	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	9.32e-06	0.000158	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NFKBIA—psoriasis	9.12e-06	0.000154	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TYK2—psoriasis	9.12e-06	0.000154	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NFKBIA—psoriasis	9.08e-06	0.000154	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CXCL8—psoriasis	8.79e-06	0.000149	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PPARG—psoriasis	8.74e-06	0.000148	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	8.69e-06	0.000147	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—LEP—psoriasis	8.6e-06	0.000146	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APOE—psoriasis	8.6e-06	0.000146	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TYK2—psoriasis	8.57e-06	0.000145	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APOE—psoriasis	8.46e-06	0.000143	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—LEP—psoriasis	8.46e-06	0.000143	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—APOE—psoriasis	8.45e-06	0.000143	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APOE—psoriasis	8.44e-06	0.000143	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—LEP—psoriasis	8.44e-06	0.000143	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—APOE—psoriasis	8.43e-06	0.000143	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APOE—psoriasis	8.41e-06	0.000142	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—LEP—psoriasis	8.41e-06	0.000142	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CAT—psoriasis	8.39e-06	0.000142	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—LEP—psoriasis	8.39e-06	0.000142	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APOE—psoriasis	8.39e-06	0.000142	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—psoriasis	8.36e-06	0.000141	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—LEP—psoriasis	8.3e-06	0.000141	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APOE—psoriasis	8.3e-06	0.000141	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CXCL8—psoriasis	8.29e-06	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—psoriasis	8.28e-06	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—LEP—psoriasis	8.28e-06	0.00014	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CARM1—psoriasis	8.2e-06	0.000139	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—JUN—psoriasis	8.17e-06	0.000138	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKBIA—psoriasis	8.01e-06	0.000136	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CXCL8—psoriasis	7.94e-06	0.000134	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—psoriasis	7.88e-06	0.000133	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKBIA—psoriasis	7.88e-06	0.000133	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NFKB1—psoriasis	7.87e-06	0.000133	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKBIA—psoriasis	7.86e-06	0.000133	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKBIA—psoriasis	7.84e-06	0.000133	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKBIA—psoriasis	7.81e-06	0.000132	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKBIA—psoriasis	7.74e-06	0.000131	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAT—psoriasis	7.72e-06	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.72e-06	0.000131	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—JUN—psoriasis	7.71e-06	0.00013	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAT—psoriasis	7.65e-06	0.00013	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—psoriasis	7.55e-06	0.000128	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TYK2—psoriasis	7.47e-06	0.000126	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CXCL8—psoriasis	7.46e-06	0.000126	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TYK2—psoriasis	7.43e-06	0.000126	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NFKB1—psoriasis	7.42e-06	0.000126	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—JUN—psoriasis	7.38e-06	0.000125	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PPARG—psoriasis	7.36e-06	0.000125	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PPARG—psoriasis	7.35e-06	0.000124	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—psoriasis	7.31e-06	0.000124	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—psoriasis	7.26e-06	0.000123	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—psoriasis	7.14e-06	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TYK2—psoriasis	7.12e-06	0.00012	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NFKB1—psoriasis	7.11e-06	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—psoriasis	7.1e-06	0.00012	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—STAT3—psoriasis	7.07e-06	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—JUN—psoriasis	6.94e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—psoriasis	6.73e-06	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NFKB1—psoriasis	6.68e-06	0.000113	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—STAT3—psoriasis	6.67e-06	0.000113	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TYK2—psoriasis	6.56e-06	0.000111	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAT—psoriasis	6.54e-06	0.000111	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—psoriasis	6.52e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CXCL8—psoriasis	6.51e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.47e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TYK2—psoriasis	6.46e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—psoriasis	6.45e-06	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TYK2—psoriasis	6.44e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TYK2—psoriasis	6.42e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TYK2—psoriasis	6.4e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—psoriasis	6.39e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TYK2—psoriasis	6.34e-06	0.000107	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—psoriasis	6.33e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TYK2—psoriasis	6.32e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CXCL8—psoriasis	6.2e-06	0.000105	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—psoriasis	6.19e-06	0.000105	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—psoriasis	6.15e-06	0.000104	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.06e-06	0.000103	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—JUN—psoriasis	6.05e-06	0.000102	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—JUN—psoriasis	6.02e-06	0.000102	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—psoriasis	6e-06	0.000102	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—psoriasis	6e-06	0.000102	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—psoriasis	5.94e-06	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—psoriasis	5.89e-06	9.97e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NFKB1—psoriasis	5.82e-06	9.86e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.79e-06	9.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—JUN—psoriasis	5.76e-06	9.75e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CXCL8—psoriasis	5.71e-06	9.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—psoriasis	5.68e-06	9.61e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.62e-06	9.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CXCL8—psoriasis	5.61e-06	9.49e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CXCL8—psoriasis	5.59e-06	9.46e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CXCL8—psoriasis	5.57e-06	9.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NFKB1—psoriasis	5.54e-06	9.39e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—psoriasis	5.52e-06	9.34e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.5e-06	9.32e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—psoriasis	5.43e-06	9.2e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—psoriasis	5.39e-06	9.13e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—psoriasis	5.34e-06	9.05e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—psoriasis	5.33e-06	9.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—psoriasis	5.32e-06	9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—JUN—psoriasis	5.31e-06	8.99e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—psoriasis	5.3e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.28e-06	8.95e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.26e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—psoriasis	5.25e-06	8.88e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.23e-06	8.86e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—psoriasis	5.23e-06	8.86e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—JUN—psoriasis	5.23e-06	8.85e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—psoriasis	5.22e-06	8.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—JUN—psoriasis	5.21e-06	8.83e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—psoriasis	5.21e-06	8.81e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—JUN—psoriasis	5.2e-06	8.8e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—JUN—psoriasis	5.18e-06	8.77e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—psoriasis	5.18e-06	8.77e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—JUN—psoriasis	5.13e-06	8.69e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—JUN—psoriasis	5.12e-06	8.66e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NFKB1—psoriasis	5.11e-06	8.65e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—psoriasis	5.09e-06	8.61e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—psoriasis	5.08e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAT—psoriasis	5.05e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.03e-06	8.52e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.03e-06	8.51e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NFKB1—psoriasis	5.02e-06	8.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NFKB1—psoriasis	5e-06	8.47e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NFKB1—psoriasis	4.99e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—psoriasis	4.98e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NFKB1—psoriasis	4.94e-06	8.36e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—psoriasis	4.94e-06	8.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.92e-06	8.34e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—psoriasis	4.87e-06	8.25e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—psoriasis	4.66e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—psoriasis	4.64e-06	7.85e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—psoriasis	4.59e-06	7.78e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—psoriasis	4.58e-06	7.76e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.56e-06	7.73e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—psoriasis	4.56e-06	7.71e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—psoriasis	4.54e-06	7.69e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—psoriasis	4.53e-06	7.66e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—psoriasis	4.52e-06	7.65e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—psoriasis	4.51e-06	7.64e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—psoriasis	4.5e-06	7.61e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—psoriasis	4.48e-06	7.59e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—psoriasis	4.48e-06	7.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.47e-06	7.57e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—psoriasis	4.46e-06	7.55e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—psoriasis	4.44e-06	7.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.43e-06	7.49e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—psoriasis	4.42e-06	7.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—psoriasis	4.19e-06	7.1e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—psoriasis	3.99e-06	6.76e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—psoriasis	3.97e-06	6.72e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—psoriasis	3.92e-06	6.64e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—psoriasis	3.8e-06	6.44e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—psoriasis	3.65e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—psoriasis	3.64e-06	6.15e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—psoriasis	3.51e-06	5.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—psoriasis	3.48e-06	5.89e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—psoriasis	3.45e-06	5.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—psoriasis	3.44e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—psoriasis	3.43e-06	5.81e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—psoriasis	3.42e-06	5.79e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—psoriasis	3.41e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—psoriasis	3.39e-06	5.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—psoriasis	3.38e-06	5.72e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—psoriasis	3.21e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—psoriasis	3.16e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—psoriasis	3.15e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—psoriasis	3.14e-06	5.32e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—psoriasis	3.13e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—psoriasis	3.1e-06	5.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—psoriasis	3.09e-06	5.23e-05	CbGpPWpGaD
